----
Current ValuationThe current P/E ratio is 66.62, above the reasonable range, cheaper than 4.76% of the time in the past 1 years, and the industry ranks 17/44, the industry Median -0.27.
66.62xP/E
$35.55Stock price
$0.53Earnings per share
66.62xP/E
Stock price$35.55Earnings per share$0.53
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 50.56x
- Typical range
- 46.88x–60.18x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
017345168
The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x20x40x60x80x100x
| Name/Symbol | |||
|---|---|---|---|
MDLNUSMedline | 66.62x | 48.22% | $46.70B |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
